Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease | Zendy

Gabriel E. Molina | Zendy; Saami Khalifian | Zendy; Jamie L. Mull | Zendy; Lu Chen | Zendy; Ilana S. Rosman | Zendy; Beverly E. Faulkner-Jones | Zendy; Kenneth Ngo | Zendy; Shadmehr Demehri | Zendy; Lynn A. Cornelius | Zendy; Peggy A. Wu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease

Author(s) -

Gabriel E. Molina,

Saami Khalifian,

Jamie L. Mull,

Lu Chen,

Ilana S. Rosman,

Beverly E. Faulkner-Jones,

Kenneth Ngo,

Shadmehr Demehri,

Lynn A. Cornelius,

Peggy A. Wu

Publication year - 2019

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2018.4793

Subject(s) - medicine , imiquimod , extramammary paget's disease , refractory (planetary science) , dermatology , calcipotriol , adverse effect , surgery , disease , psoriasis , physics , astrobiology

Extramammary Paget disease (EMPD), a rare intraepithelial adenocarcinoma, poses a therapeutic challenge with high postoperative recurrence rates and a limited number of effective local treatment options.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research